Contract facts
FederalBPA FOR PLUVICTO AND LUTATHERA INJECTION is a federal award for Defense Health Agency Hcd West held by Novartis Pharmaceuticals Corp. Estimated value —.
Want the durability read on HT941026AE002? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNovartis Pharmaceuticals Corp — $23.5M obligated across 59 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT941026AE002?
HT941026AE002 (BPA for pluvicto and lutathera injection) is a Defense Health Agency Hcd West award with an estimated value of —, currently held by Novartis Pharmaceuticals Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT941026AE002?
Defense Health Agency Hcd West awarded HT941026AE002 to Novartis Pharmaceuticals Corp.
Who is the incumbent on HT941026AE002?
Novartis Pharmaceuticals Corp is the incumbent with $23.5M across 59 related awards in SCOUT’s public footprint.
When does Novartis Pharmaceuticals Corp’s HT941026AE002 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT941026AE002? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.